Login / Signup

Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center.

Woon Hyung ChaeAnnika VössingYan LiCornelius DeuschlLennart Steffen MillesJordi Kühne EscolàAnika HüsingMarvin Darkwah OppongPhilipp DammannMartin GlasMichael ForstingChristoph KleinschnitzMartin KöhrmannBenedikt Frank
Published in: Therapeutic advances in neurological disorders (2023)
Recanalization therapy in AIS patients with active malignancy was not associated with a higher risk for stroke treatment-related systemic or intracranial bleeding. IVT and/or EVT can be regarded as a safe therapy option for AIS patients with active malignancy.
Keyphrases
  • acute ischemic stroke
  • atrial fibrillation
  • stem cells
  • mesenchymal stem cells
  • replacement therapy
  • brain injury
  • blood brain barrier
  • cerebral ischemia
  • optic nerve